Reports for CANDESARTAN CILEXETIL
Ingredient
CANDESARTAN CILEXETIL
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Resolved | 2022-10-28 | 2022-12-15 | 173031 |
SANDOZ CANDESARTAN | 16MG | TABLET | Resolved | 2022-11-02 | 2022-12-28 | 173367 |
SANDOZ CANDESARTAN | 4MG | TABLET | Resolved | 2022-11-16 | 2022-11-29 | 174897 |
SANDOZ CANDESARTAN | 8MG | TABLET | Resolved | 2022-11-16 | 2022-11-29 | 174968 |
SANDOZ CANDESARTAN PLUS | 12.5MG 16MG | TABLET | Resolved | 2022-11-28 | 2022-12-12 | 176046 |
SANDOZ CANDESARTAN | 16MG | TABLET | Resolved | 2022-11-28 | 2022-12-12 | 176049 |
SANDOZ CANDESARTAN | 32MG | TABLET | Resolved | 2022-12-28 | 2023-01-19 | 179495 |
SANDOZ CANDESARTAN | 16MG | TABLET | Resolved | 2022-12-28 | 2023-03-06 | 179502 |
TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2023-01-19 | 2023-06-09 | 181599 |
TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2023-01-19 | 2023-04-28 | 181605 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65050 | ||
ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65052 | ||
ACT CANDESARTAN | 4MG | TABLET | Discontinued | 2018-10-22 | 2018-10-22 | 65171 |